Document is current

Any future updates will be listed below

What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12890-024-03438-3

Published Online: 2024-12-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark